» Articles » PMID: 9858536

Mechanism of Regulatory Target Selection by the SOX High-mobility-group Domain Proteins As Revealed by Comparison of SOX1/2/3 and SOX9

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1998 Dec 22
PMID 9858536
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

SOX proteins bind similar DNA motifs through their high-mobility-group (HMG) domains, but their action is highly specific with respect to target genes and cell type. We investigated the mechanism of target selection by comparing SOX1/2/3, which activate delta-crystallin minimal enhancer DC5, with SOX9, which activates Col2a1 minimal enhancer COL2C2. These enhancers depend on both the SOX binding site and the binding site of a putative partner factor. The DC5 site was equally bound and bent by the HMG domains of SOX1/2 and SOX9. The activation domains of these SOX proteins mapped at the distal portions of the C-terminal domains were not cell specific and were independent of the partner factor. Chimeric proteins produced between SOX1 and SOX9 showed that to activate the DC5 enhancer, the C-terminal domain must be that of SOX1, although the HMG domains were replaceable. The SOX2-VP16 fusion protein, in which the activation domain of SOX2 was replaced by that of VP16, activated the DC5 enhancer still in a partner factor-dependent manner. The results argue that the proximal portion of the C-terminal domain of SOX1/2 specifically interacts with the partner factor, and this interaction determines the specificity of the SOX1/2 action. Essentially the same results were obtained in the converse experiments in which COL2C2 activation by SOX9 was analyzed, except that specificity of SOX9-partner factor interaction also involved the SOX9 HMG domain. The highly selective SOX-partner factor interactions presumably stabilize the DNA binding of the SOX proteins and provide the mechanism for regulatory target selection.

Citing Articles

SUMO-dependent transcriptional repression by Sox2 inhibits the proliferation of neural stem cells.

Marelli E, Hughes J, Scotting P PLoS One. 2024; 19(3):e0298818.

PMID: 38507426 PMC: 10954124. DOI: 10.1371/journal.pone.0298818.


Biallelic Variants Associated With Novel Syndrome With Myopathy, Skeletal Deformities, Intellectual Disability, and Ovarian Dysfunction.

Warman-Chardon J, Hartley T, Marshall A, McBride A, Couse M, MacDonald W Neurol Genet. 2024; 9(5):e200088.

PMID: 38235364 PMC: 10508790. DOI: 10.1212/NXG.0000000000200088.


Characterization of Schistosome Sox Genes and Identification of a Flatworm Class of Sox Regulators.

Wood S, Ishida K, Hagerty J, Karahodza A, Dennis J, Jolly E Pathogens. 2023; 12(5).

PMID: 37242360 PMC: 10222431. DOI: 10.3390/pathogens12050690.


Novel Variants of in Patients with Intellectual Disability.

Grosse M, Kuechler A, Dabir T, Spranger S, Beck-Wodl S, Bertrand M Int J Mol Sci. 2023; 24(4).

PMID: 36834931 PMC: 9964377. DOI: 10.3390/ijms24043519.


The Effects of Bilirubin and Lumirubin on the Differentiation of Human Pluripotent Cell-Derived Neural Stem Cells.

Capkova N, Pospisilova V, Fedorova V, Raska J, Pospisilova K, Dal Ben M Antioxidants (Basel). 2021; 10(10).

PMID: 34679668 PMC: 8532948. DOI: 10.3390/antiox10101532.


References
1.
Hayashi S, Scott M . What determines the specificity of action of Drosophila homeodomain proteins?. Cell. 1990; 63(5):883-94. DOI: 10.1016/0092-8674(90)90492-w. View

2.
Streit A, Sockanathan S, Perez L, Rex M, Scotting P, Sharpe P . Preventing the loss of competence for neural induction: HGF/SF, L5 and Sox-2. Development. 1997; 124(6):1191-202. DOI: 10.1242/dev.124.6.1191. View

3.
Giese K, Amsterdam A, Grosschedl R . DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1. Genes Dev. 1991; 5(12B):2567-78. DOI: 10.1101/gad.5.12b.2567. View

4.
Ng L, Wheatley S, Muscat G, Bowles J, Wright E, Bell D . SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol. 1997; 183(1):108-21. DOI: 10.1006/dbio.1996.8487. View

5.
Bell D, Leung K, Wheatley S, Ng L, Zhou S, Ling K . SOX9 directly regulates the type-II collagen gene. Nat Genet. 1997; 16(2):174-8. DOI: 10.1038/ng0697-174. View